Location: Home
  • search
  • go
  • Relate News
  • 11/27/2017AstraZeneca and FIIF Establish Joint Venture to Develop New Medicines ...
  • 11/24/2017Recent Executive Moves
  • 11/23/2017Investors Place Bet on Chinese Drugmakers
  • 11/23/2017China's FDA Reform Will Encourage Life Science Innovation
  • 11/23/2017NDRC Issues the Guidelines for Pricing Behaviors of Shortage Drug and ...
  • 11/23/2017CAR-T Startup Immunochina Raises CNY 50M to Further Its Cell and Gene ...
  • 11/23/2017CFDA Approves Clinical Trial of Chinese-developed 2nd Generation HPV V...
  • 11/22/2017Eleison Pharma to Partner with Lee's Pharma for Glufosfamide in China
  • 11/22/2017Guangzhou Pharma Reveals Grand Plan
  • 11/22/2017Fresenius Kabi Terminates Oncology Business Division in China
  • 11/22/2017Sichuan Kelun Pharma Acquires 20% Stake of Competitor Shijiazhuang No....
  • 11/22/2017PwC: Overseas Investments by Chinese Pharma Cos Up as Domestic M&A...
  • 11/22/2017RiboBio and GE Healthcare Forges Partnership for Oligonucleotide Drug ...
  • 11/21/2017Chengdu Kanghong Pharma to Acquire Israel's IOPtima
  • 11/20/2017Acasti Pharma to License Its Hypertriglyceridemia Drug to Chinese Part...
  • 11/19/2017Listed Chinese Pharma Cos Remain Major Advertisers in H1/2017
  • 11/19/2017Domestically-listed Companies Maintains Growth in First 3Qs of 2017
  • 11/16/2017Recent Official and Executive Moves
  • 11/16/2017Shanghai Pharma Eyes Acquisitions in the U.S. and Europe Following Car...
  • 11/15/2017Fujian-led Inter-provincial Drug Purchase Alliance Imminent
  • 11/15/2017Update on Antitrust Legislative Development in China
  • 11/15/2017Competition Impact Review to Be Required for All New Chinese Regulatio...
  • 11/15/2017China Issues New Measure to Ensure Fair Competition
  • 11/15/2017Is Walgreens Boots Alliance Pulling Out of Chinese JV Guangzhou Pharma
  • 11/14/2017Reckitt Benckiser, Alibaba Join Hands to Market Quality Health Product...
  • 11/14/2017Shanghai Pharma Buys Cardinal Health's China Business for $1.2B
  • 11/13/2017XiAn Janssen Launches IMBRUVICA (ibrutinib) in China
  • 11/13/2017Pfizer Divests from Chinese JV with Hisun
  • 11/9/2017AstraZeneca Bets on Continued Growth in China as GSK Fades
  • 11/9/2017Recent Executive Moves
  • Page:175/359 Total number of articles:10741: [First][<<] [173] [174] [175] [176] [177] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group